Alberto Utrero-Rico

9PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Psycholinguistics (incl. speech production and comprehension)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 05, 2026
Differential effects of GVHD therapies on intestinal epithelium.

Alberto Utrero-Rico, Urvi Kapoor, Brenden Berrios

|Mar 07, 2025
Delineation of monocytic and early-stage myeloid-derived suppressor cells in the peripheral blood of patients with hepatocarcinoma.

Marta Chivite-Lacaba, Iago Justo, Alberto Utrero-Rico

|Dec 20, 2023
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects.

Mariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico

|Sep 14, 2023
Lactate dehydrogenase contribution to symptom persistence in long COVID: A pooled analysis.

Raphael Udeh, Alberto Utrero-Rico, Xenia Dolja-Gore

|Feb 25, 2022
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution.

Francisco Javier Gil-Etayo, Sara Garcinuño, Alberto Utrero-Rico

|Dec 28, 2021
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.

Patricia Almendro-Vázquez, Rocio Laguna-Goya, Maria Ruiz-Ruigomez

Pageof 2